Related Experiment Video
Updated: Jul 12, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs
Nobubelo G Ngandu1, Helba Bredell, Clive M Gray
1Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Medical School, Observatory, South Africa 7925.
Insights
Cytotoxic T lymphocyte (CTL) responses are key for controlling HIV-1. This study found that CTL epitope recognition in HIV-1 subtype C is linked to both conserved and variable regions, with predictions often mismatching actual responses, impacting vaccine design.
Area of Science:
- Immunology
- Virology
- Vaccine Research
Background:
- Cytotoxic T lymphocyte (CTL) responses are crucial for controlling HIV-1 replication.
- Developing effective HIV-1 vaccines relies on eliciting robust CTL responses.
Purpose of the Study:
- To investigate the relationship between CTL responses and sequence diversity in HIV-1 subtype C.
- To assess the accuracy of predicting CTL responses based on HLA genotype for HIV-1 subtype C.
Main Methods:
- Statistical analysis of CTL recognition sites in HIV-1 Nef, p24, and p17 proteins.
- Comparison of observed CTL responses with predicted responses based on HLA-A and -B binding motifs in subtype C and B datasets.
Main Results:
- CTL recognition of Nef and p24 peptides was associated with conserved regions, while p17 recognition occurred in variable regions.
- Predicted CTL responses based on HLA genotype were less accurate for subtype C (52-64%) compared to subtype B (83-96%).
- Discrepancies in subtype C are likely due to poorly characterized Southern African HLA alleles and overspecified binding motifs for subtype B.
Conclusions:
- HLA binding motif knowledge may be biased towards specific populations and subtypes.
- Understanding these biases is critical for interpreting immune escape and predicting vaccine efficacy in diverse HIV-1 populations.
- Findings have implications for HIV vaccine design and monitoring, particularly for non-B subtypes.
Abstract:
Cytotoxic T lymphocyte (CTL) responses are thought to be essential for the control of HIV-1 replication in vivo and immunogens that elicit CTL responses are currently a major focus of HIV vaccine research. Here we investigated two aspects of the CTL response to HIV-1 subtype C that are important for vaccine design and efficacy monitoring. First, we assessed the relationship between the CTL response and sequence diversity, using a robust statistical method. While peptides that were most frequently recognized by the CTL response in Nef and p24 tended to be conserved, this was not the case for p17 where epitope recognition coincided with highly variable regions. Second, we investigated the relationship between observed and predicted CTL responses, given the HLA genotype of infected individuals. Only 52% of the Nef peptides and 64% of the Gag peptides that elicited a CTL response contained sequence motifs thought to be required for binding by the HLA-A or -B alleles found in the corresponding patient. In a comparable subtype B dataset a much higher proportion of the peptides that elicited a CTL response were consistent with the patient HLA genotype (96% and 83% for Nef and Gag, respectively). We demonstrate that this difference between subtypes C and B is likely to result from a combination of a tendency for HLA alleles common in Southern African populations to be poorly characterized, as well as a tendency for sequence motifs associated with HLA recognition to be overspecified for sequence variation found in the B clade. Our results suggest that knowledge of HLA binding motifs is likely to be biased toward certain populations and subtypes. This can have important implications for understanding immune escape and predicting vaccine efficacy in the context of populations primarily infected with non-B subtype HIV-1.
